论文部分内容阅读
目的 :探讨肝转移治疗 (TAITAE)和预后间的关系。方法 :回顾分析山东省肿瘤防治研究院1995年 5月～ 1997年 5月收治的 63例肝转移瘤介入治疗患者。结果 :总有效率 (CR +PR) 87.3%。 6个月、1年、2年生存率分别为 92 .0 %、71.4 %、33.3%。结论 :介入治疗是转移性肝癌的一种有效方法 ,具有疗效高、副作用小、生存期延长等优点
Objective: To investigate the relationship between the treatment of liver metastases (TAITAE) and prognosis. Methods: A retrospective analysis of Shandong Cancer Institute from May 1995 to May 1997 admitted 63 cases of liver metastases in patients with interventional therapy. Results: The total effective rate (CR + PR) 87.3%. The 6-month, 1-year and 2-year survival rates were 92.0%, 71.4% and 33.3% respectively. Conclusion: Interventional therapy is an effective method for metastatic liver cancer with the advantages of high curative effect, small side effects and prolonged survival